Genetic issues in pediatric pancreatitis

Current Gastroenterology Reports

Volumn 8, Issue 3, 2006, Pages 248-253

  Kandula, Leena ^b   Whitcomb, David C ^b   Lowe, Mark E ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; CHILD; CHILDHOOD DISEASE; CHRONIC PANCREATITIS; CYTOLOGY; DISEASE COURSE; DISEASE SEVERITY; FREQUENCY ANALYSIS; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HOSPITALIZATION; HUMAN; INFLAMMATION; MORBIDITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

CARRIER PROTEINS; CHILD; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PANCREATITIS; POLYMORPHISM, GENETIC; TRYPSINOGEN;

EID: 33744969302     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-006-0083-8     Document Type: Review

References (49)

1. Whitcomb DC, Gorry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141-145.
2. Rinderknecht H: Pancreatic secretary enzymes. In The Pancreas: Biology, Pathobiology, and Disease. New York: Raven Press; 1993:219-251.
3. Whitcomb DC: Early trypsinogen activation in acute pancreatitis. Gastroenterology 1999, 116:770-773.
4. Frossard JL, Past CM: Experimental acute pancreatitis: new insights into pathophysiology. Front Biosci 2002, 7:275-287.
5. Fernandez-del Castillo C, Schmidt J, Warshaw AL, Rattner DW: Interstitial protease activation is the central event in progression to necrotizing pancreatitis. Surgery 1994, 116:497-504.
6. Cavallini G, Tittobello A, Frulloni L, et al.: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996, 335:919-923.
7. Whitcomb DC: Genetic predisposition to acute and chronic pancreatitis. Med Clin North Am 2000, 84:531-547.
8. Whitcomb DC: Hereditary pancreatitis: new insights into acute and chronic pancreatitis. Gut 1999, 45:317-322.
9. Ward JB, Peterson OH, Jenkins SA, Sutton R: Is an elevated concentration of acinar cytosolic free ionized calcium the trigger for acute pancreatitis? Lancet 1995, 346:1016-1019.
10. Gorry MC, Gabbaizedeh D, Furey W, et al.: Multiple mutations in the cationic trypsinogen gene are associated with hereditary pancreatitis. Gastroenterology 1997, 113:1063-1068.
11. Schneider A, Whitcomb DC: Hereditary pancreatitis: a model for inflammatory diseases of the pancreas. Best Pract Res Clin Gastroenterol 2002, 16:347-363.
12. Comfort M, Steinberg A: Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952, 21:54-63.
13. Khalid A, Finkelstein S, Thompson B, et al.: A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression and without pancreatitis: insights into phenotypic non-penetrance. Gut 2005. Dec 14; [Epub ahead of print].
14. Amann ST, Gates LK, Aston CE, et al.: Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins. Gut 2001, 48:542-547.
15. Sibert JR: Hereditary pancreatitis in England and Wales. J Med Genet 1978, 15:189-201.
16. Keim V, Bauer N, Teich N, et al.: Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med 2001, 111:622-626.
17. Kattwinkel J, Lapey A, Di Sant'Agnese PA, Edwards WA: Hereditary pancreatitis: three new kindreds and a critical review of the literature. Pediatrics 1973, 51:55-69.
18. Elitsur Y, Hunt JA, Chertow BS: Hereditary pancreatitis in the children of West Virginia. Pediatrics 1994, 93:528-531.
19. Witt H: Gene mutations in children with chronic pancreatitis. Pancreatology 2001, 1:432-438.
20. Oralewska B, Oracz G, Sobczynska-Tomaszewska A, et al.: Hereditary pancreatitis in children: SY1-02. J Pediatr Gastroenterol Nutr 2005, 40:630.
21. Konzen KM, Perrault J, Moir C, Zinsmeister AR: Long-term follow-up of young patients with chronic hereditary or idiopathic pancreatitis. Mayo Clin Proc 1993, 68:449-453.
22. Howes N, Lerch MM, Greenhalf W, et al.: Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004, 2:252-261.
23. Witt H, Luck W, Hennies HC, et al.: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000, 25:213-216.
24. Pfutzer RH, Barmada MM, Brunskill AP, et al.: SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000, 119:615-623.
25. Chen JM, Mercier B, Audrezet MP, et al.: Mutations of the pancreatic secretary trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 2001, 120:1061-1064.
26. Plendl H, Siebert R, Steinemann D, Grote W: High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay. Am J Med Genet 2001, 100:252-253.
27. Rossi L, Pfutzer RH, Parvin S, et al.: SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report. Pancreatology 2001, 1:242-245.
28. Whitcomb DC: Value of genetic testing in the management of pancreatitis. Gut 2004, 53:1710-1717.
29. del Rosario JF, Putnam PE, Orenstein DM: Chronic pancreatitis in a patient with cystic fibrosis and clinical pancreatic insufficiency. J Pediatr 1995, 126:951-952.
30. De Boeck K, Weren M, Proesmans M, Kerem E: Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics 2005, 115:463-469.
31. Durno C, Corey M, Zielenski J, et al.: Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002, 123:1857-1864.
32. Zielenski J, Tsui LC: Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995, 29:777-807.
33. Atlas AB, Orenstein SR, Orenstein DM: Pancreatitis in young children with cystic fibrosis. J Pediatr 1992, 120:756-759.
34. Durie, PR: Pancreatitis and mutations of the cystic fibrosis gene. N Engl J Med 1998, 339: 687-688.
35. Shwachman H, Lebenthal E, Khaw KT: Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. Pediatrics 1975, 55:86-95.
36. Cohn JA, Friedman KJ, Noone PG, et al.: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998, 339:653-658.
37. Sharer N, Schwarz M, Malone G, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998, 339:645-652.
38. Pezzilli R, Morselli-Labate AM, Mantovani V, et al.: Mutations of the CFTR gene in pancreatic disease. Pancreas 2003, 27:332-336.
39. Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001, 121:1310-1319.
40. Beranek H, Teich N, Witt H, et al.: Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur J Gastroenterol Hepatol 2003, 15:1223-1227.
41. Zhang D, Li J, Jiang ZW, et al.: Association of two polymorphisms of tumor necrosis factor gene with acute severe pancreatitis. J Surg Res 2003, 112:138-143.
42. Papachristou GI, Sass DA, Avula H, et al.: Is the monocyte chemotactic protein-1-2518 G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol 2005, 3:475-481.
43. Van Laethem JL, Eskinazi R, Louis H, et al.: Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998, 43:408-413.
44. Han XC, Zhang YC, Wang Y, Jia MK: Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int 2003, 2:135-138.
45. Ellis I, Lerch MM, Whitcomb DC et al.: Genetic testing for hereditary pancreatitis: guidelines for indications, counseling, consent and privacy issues. Pancreatology 2001, 1:405-415.
46. Whitcomb DC: Motion-genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: arguments for the motion. Can J Gastroenterol 2003, 17:47-52.
47. Cohn JA: Motion-genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: arguments against the motion. Can J Gastroenterol 2003, 17:53-55.
48. Applebaum SE, Kant JA, Whitcomb DC, Ellis IH: Genetic testing: Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med Clin North Am 2000, 84:575-588.
49. Ellis I: Genetic counseling for hereditary pancreatitis: the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type I. Gastroenterol Clin N Am 2004, 33:839-854.